Showing results (171-180 of 292) with videos related to

Sort By:
Pageof 30
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 3, 2020
Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and AustraliaKarina A Top, Kristine Macartney, Julie A Bettinger, et al.
The Pediatric Infectious Disease Journal|September 17, 2015
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013Tina Tan, Tine Dalby, Kevin Forsyth, et al.
Human Vaccines & Immunotherapeutics|January 6, 2026
Healthcare providers' awareness, attitudes, beliefs, and practices surrounding pharmacist-administered vaccination: Insights after a two-year interventionAntonia M Di Castri, Donna M Halperin, Jennifer E Isenor, et al.
Infection|November 6, 2023
Antibiotic use in children hospitalised for influenza, 2010-2021: the Canadian Immunization Monitoring Program Active (IMPACT)Tilmann Schober, Shaun K Morris, Julie A Bettinger, et al.
Vaccine|February 3, 2007
Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adultsShelly A McNeil, Francisco Noya, Marc Dionne, et al.
The Journal of Infectious Diseases|October 4, 2016
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum AdjuvantJoanne M Langley, Naresh Aggarwal, Azhar Toma, et al.
Vaccine|December 23, 2023
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) studyJoanne M Langley, Soren Gantt, Scott A Halperin, et al.
Vaccine|January 28, 2020
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)Julie A Bettinger, Paul Liberator, Scott A Halperin, et al.
BMC Public Health|December 6, 2025
The impact of two-year community-wide pharmacy interventions on the public's knowledge, attitudes, beliefs and behaviors about pharmacists as immunizersDonna M Halperin, Antonia M Di Castri, Jennifer E Isenor, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccineScott A Halperin, Brian J Ward, Marc Dionne, et al.
Pageof 30